# Ant Group's MaYi A Fu goes mainstream: 15M users, stocks rally, hospital AI rollouts across China, and an IPO on the way

> Ant's MaYi A Fu is surging-#3 on the App Store, 15M MAU, and 5M+ daily health queries as funds pile in. For care leaders: link APIs, measure conversion, prep data governance.

- Type: AI news
- Page: https://completeaitraining.com/news/ant-groups-mayi-a-fu-goes-mainstream-15m-users-stocks-rally/
- Published: 2025-12-25
- Updated: 2026-02-18
- Author: Jeroen Erne
- Jobs: Healthcare
- Reading time: 2 min

### Ant Group's "MaYi A Fu" AI Health App Goes Viral - What Healthcare Leaders Should Do Next

Published: December 24, 2025 \* Reading time: 2 minutes

Ant Group's upgraded AI health app, **MaYi A Fu**, has broken out since its December 15 release. It reached **\#3 on Apple's App Store**, crossed **15 million monthly active users**, handles **5+ million daily health queries**, and posted an **83% Q3 MAU growth rate** versus an industry average of 13.5%.

Healthcare leaders should review strategic implications for delivery, operations, and partnerships: [AI for Executives & Strategy](https://completeaitraining.com/tag/executives-and-strategy/).

The momentum isn't just consumer buzz. The Wind AI Healthcare Index rose for three straight sessions after launch. As of December 23, Huakang Jieyi jumped **34%+**, Jiahe Meikang **14%+**, and Chutian Technology **8%+**.

#### Why this matters for care delivery

MaYi A Fu centers on **AI health companionship, Q&A, and services**; see practical use cases and deployment patterns in [AI for Healthcare](https://completeaitraining.com/tag/healthcare/). With Ant's payments and insurance rails, it points to a practical **medical + pharma + insurance** closed loop that can route users from chat to transaction to follow-up.

This shifts AI from a single feature to a **front door for consumer health**: intake, triage, adherence, and chronic condition support-then handoff to offline care when needed. For health systems and payers, it's a new access channel with measurable conversion and cost metrics.

#### Signals you should track

- **Hospital infrastructure:** China's top 100 hospitals have deployed large models; vendors like Yunzhisheng and iFlytek Medical are embedding AI across full diagnostic workflows.
- **AI drug discovery:** Insilico Medicine targets a Hong Kong listing on December 30; its platform has **20+ clinical-stage assets**. [Insilico Medicine](https://insilico.com/?ref=completeaitraining.com)
- **Brokerage views:** Everbright Securities highlights AI companionship as a new path to commercialization via Ant's payment/insurance stack. CITIC Securities notes expansion from single products to full scenarios, reaching grassroots clinics and individuals.

#### Practical moves for providers and payers

- **Integration path:** Explore partnership/APIs with MaYi A Fu to route triage, scheduling, and pharmacy orders. Define handoffs to your call centers, clinics, and care teams.
- **Measure what matters:** Track cost per resolved query, escalation rate to clinicians, wait time reduction, no-show impact, and adherence uplift.
- **Device connectivity:** Prioritize home devices with stable data pipelines (BP cuffs, glucometers, wearables). Use readings to trigger nudges and virtual follow-ups.
- **Data governance:** Enforce explicit consent, PHI segregation, model performance review, and audit trails. Maintain human-in-the-loop for high-risk cases.
- **Coverage and billing:** Map benefits where Ant's payment/insurance stack can shorten prior auth, co-pay collection, and reimbursement cycles (see [AI for Insurance](https://completeaitraining.com/tag/insurance/)).

#### Moves for pharma and retail health

- **Traffic capture:** Build condition paths from AI chat to pharmacist chat, e-Rx, and local pickup. Optimize for refill adherence and care gaps.
- **Evidence and safety:** Use AI-first cohorts for real-world evidence, education, and pharmacovigilance. Keep content medically reviewed and timestamped.

#### Where investors see opportunity

- **Home medical devices** integrated with MaYi A Fu.
- **Offline physical exam providers** (e.g., Meinian Health) supplying structured data into AI flows.
- **Pharmaceutical retail and internet medical platforms** converting AI traffic to paid services.

Analysts still view AI healthcare as early-but with meaningful upside as usage turns into clinical outcomes and revenue.

#### What to watch next

- Conversion from MAU to paid services, pharmacy orders, and insured claims.
- AI performance in tier-2/3 cities and grassroots settings.
- Regulatory guidance on data use, safety, and marketing claims.

#### Resources

- [Ant Group](https://www.antgroup.com/?ref=completeaitraining.com)
- AI courses by job roles (for healthcare teams)

---

This is the Markdown form of https://completeaitraining.com/news/ant-groups-mayi-a-fu-goes-mainstream-15m-users-stocks-rally/. The whole site is mapped at https://completeaitraining.com/llms.txt.
